Cerimon Pharmaceuticals, Inc., announced it hold initiate a Phase I clinical enquiry of a new-fangled diclofenac sodium patch, the Company’s forefront discomfort desirable quality. The study will authority sanctuary, tolerability, and systemic pharmacokinetics of a topical patch formulation of diclofenac sodium, a non-steroidal anti-inflammatory linctus (NSAID), inwardly 16 unprocessed volunteers. The Phase I [...]
Entries from January 2009
Cerimon Pharmaceuticals Initiates Phase I Clinical Study Of Topical Diclofenac Sodium Patch
January 27th, 2009 · No Comments
Tags: Uncategorized
Genaera Corporation Begins Dosing In Phase 1 Trial Of Obesity Compound Trodusquemine
January 24th, 2009 · No Comments
Genaera Corporation (Nasdaq: GENR) today announced that dose of thesis have begin surrounded via sanctum MSI-1436C-101, the Phase 1, first-in-man study of trodusquemine (MSI- 1436), its new-fangled anti-obesity multipart. MSI-1436 works centrally and peripherally to correct insulin and leptin receptor signaling through inhibition of its novel target enzyme PTP-1B.
This randomized, vehicle-controlled [...]
Tags: Uncategorized
